- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Natco Pharma Ltd. (NATP)
Natco Pharma Ltd. stock price live, this page displays NSE NATP stock exchange data. View the NATP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Natco Pharma Ltd. real time stock price chart below.
What Is the Natco Pharma Ltd. Stock Price Today?
The Natco Pharma Ltd. stock price today is 869.05.
What Is the Stock Symbol for Natco Pharma Ltd.?
The stock symbol for Natco Pharma Ltd. is "NATP."
What Stock Exchange Does Natco Pharma Ltd. Trade On?
Natco Pharma Ltd. is listed and trades on the NSE stock exchange.
Is Natco Pharma Ltd. a Good Stock to Buy?
Determining whether Natco Pharma Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NATP quote. (ISIN: INE987B01026)
What Is the Natco Pharma Ltd. Stock Price Today?
The Natco Pharma Ltd. stock price today is 869.05.
What Is the Stock Symbol for Natco Pharma Ltd.?
The stock symbol for Natco Pharma Ltd. is "NATP."
What Stock Exchange Does Natco Pharma Ltd. Trade On?
Natco Pharma Ltd. is listed and trades on the NSE stock exchange.
Is Natco Pharma Ltd. a Good Stock to Buy?
Determining whether Natco Pharma Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NATP quote. (ISIN: INE987B01026)
869.05
-0.15(-0.02%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
867.45
882.70
52 wk Range
726.80
1,639.00
NATP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NATP is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
867.45882.70
52 wk Range
726.801,639.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NATP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
967.45
Upside
+11.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Natco Pharma Company Profile
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Compare NATP to Peers and Sector
Metrics to compare | NATP | Peers Peers - average of corresponding metrics from companies closely matching NATP: ALKEM, JBCHEPHARM, LAURUSLABS, TORNTPHARM, INDOCO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNATPPeersSector |
|---|---|---|---|---|
P/E Ratio | 8.3x | 33.6x | −0.5x | |
PEG Ratio | 0.23 | 0.85 | 0.00 | |
Price/Book | 2.1x | 5.4x | 2.6x | |
Price / LTM Sales | 3.5x | 6.1x | 3.0x | |
Upside (Analyst Target) | 9.5% | 10.4% | 52.5% | |
Fair Value Upside | Unlock | −5.9% | 8.7% | Unlock |
Analyst Ratings
3 Buy
3 Hold
4 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 967.45
(+11.32% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
22.85 / 32.20
Revenue / Forecast
12.21B / 14.36B
FAQ
What Is the Natco Pharma (NATP) Stock Price Today?
The Natco Pharma stock price today is 869.05.
What Stock Exchange Does Natco Pharma Trade On?
Natco Pharma is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Natco Pharma?
The stock symbol for Natco Pharma is "NATP."
Does Natco Pharma Pay Dividends? What’s The Current Dividend Yield?
The Natco Pharma dividend yield is 0.69%.
What Is the Natco Pharma Market Cap?
As of today, Natco Pharma market cap is 155.47B.
What Is Natco Pharma's Earnings Per Share (TTM)?
The Natco Pharma EPS (TTM) is 105.26.
When Is the Next Natco Pharma Earnings Date?
Natco Pharma will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is NATP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Natco Pharma Stock Split?
Natco Pharma has split 1 times.
How Many Employees Does Natco Pharma Have?
Natco Pharma has 4016 employees.
What is the current trading status of Natco Pharma (NATP)?
As of 24 Jun 2025, Natco Pharma (NATP) is trading at a price of 869.05, with a previous close of 869.20. The stock has fluctuated within a day range of 867.45 to 882.70, while its 52-week range spans from 726.80 to 1,639.00.
What Is Natco Pharma (NATP) Price Target According to Analysts?
The average 12-month price target for Natco Pharma is INR967.45455, with a high estimate of INR1480 and a low estimate of INR697. 3 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +11.32% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.